UBS Maintains Neutral on Stryker, Raises Price Target to $351
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Danielle Antalffy maintains a Neutral rating on Stryker (SYK) and raises the price target from $339 to $351.
May 01, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS maintains a Neutral rating on Stryker and raises the price target from $339 to $351.
The increase in price target by UBS suggests a positive outlook on Stryker's stock value in the short term, potentially leading to an upward movement in its stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 90